Bumper Offer - Urjas oil Just @ Rs. 1 X
Floxip Drop is a prescription drug, available for use as Drops. It is typically used for the treatment of Urinary Tract Infection, Bacterial Infections. Floxip Drop also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Floxip Drop. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Floxip Drop can also lead to other problems, which have been listed below. These side effects of Floxip Drop are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Floxip Drop has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Floxip Drop's effects on the liver, heart and kidney are discussed below in the Floxip Drop related warnings section.
Floxip Drop can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Floxip Drop in conditions like Arrhythmia, Heart Disease, Myasthenia Gravis (MG). Some other conditions that can be affected by Floxip Drop are listed in the contraindications section below.
Besides this, Floxip Drop may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Floxip Drop is considered not safe while driving, and is not addictive.
Floxip Drop is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
Based on research, the following side effects have been observed when Floxip Drop is used -
Severe
Moderate
Mild
Is the use of Floxip Drop safe for pregnant women?
Floxip may have some side effects during pregnancy. Pregnant women should discontinue the use of Floxip, and talk to their doctor, if they notice any discomfort.
Is the use of Floxip Drop safe during breastfeeding?
Floxip can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Floxip Drop on the Kidneys?
Floxip may have mild side effects on the kidneys.
What is the effect of Floxip Drop on the Liver?
Floxip has very mild side effects on the liver.
What is the effect of Floxip Drop on the Heart?
Floxip may have mild side effects on the heart. Most people will never see any effect on the heart.
Floxip Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Floxip Drop unless your doctor advises you to do so -
Is this Floxip Drop habit forming or addictive?
You may get addicted to Floxip Drop. Therefore, before taking it, consult your doctor.
Is it safe to drive or operate heavy machinery when consuming?
After taking Floxip Drop you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Floxip Drop is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Floxip Drop is unable to treat or cure mental disorders.
Interaction between Food and Floxip Drop
Taking certain foods and Floxip Drop together may have severe side effects. Talk to your doctor about it.
Interaction between Alcohol and Floxip Drop
Consumption of alcohol and Floxip Drop together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cipro® (ciprofloxacin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 710-713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cipro® (ciprofloxacin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 710-713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tindamax® (tinidazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cipro® (ciprofloxacin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 710-713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cipro® (ciprofloxacin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 710-713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cipro® (ciprofloxacin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 710-713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cipro® (ciprofloxacin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 710-713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584